Therapeutic Area Market Research Reports & Industry Analysis
Therapeutic areas include Cardiology/Vascular Diseases, Dental and Oral Health, Dermatology, Devices, Endocrinology, Family Medicine, Gastroenterology, Genetic Disease, Healthy Volunteers, Hematology, Hepatology, Immunology, Infections and Infectious Diseases, Internal Medicine, Musculoskeletal, Nephrology, Neurology, Nutrition and Weight Loss, Obstetrics/Gynecology, Oncology, Ophthalmology, Orthopedics/Orthopedic Surgery, Otolaryngology, Pediatrics/Neonatology, Pharmacology/Toxicology, Podiatry, Psychiatry/Psychology, Pulmonary/Respiratory Diseases, Rheumatology, Sleep, Trauma, Urology, and Vaccines.
Reports in these categories will contain statistics of prevalence and growth concerning therapeutic area diseases for which there are product reviews, market size, and share for products that are used in pharmaceutical treatment or equipment that used in surgical treatment of the therapeutic area.
Therapeutic Area Industry Research & Market Reports
-
Intracranial Aneurysm
... CAGR of 8.7% over the analysis period 2024-2030. Endovascular Coiling, one of the segments analyzed in the report, is expected to record a 8.5% CAGR and reach US$2.3 Billion by the end of the analysis ... Read More
-
Liver Cancer Diagnostics
... at a CAGR of 7.4% over the analysis period 2024-2030. Laboratory Tests, one of the segments analyzed in the report, is expected to record a 8.4% CAGR and reach US$9.8 Billion by the end of ... Read More
-
Pediatric Imaging
... CAGR of 7.1% over the analysis period 2024-2030. Magnetic Resonance Imaging, one of the segments analyzed in the report, is expected to record a 7.5% CAGR and reach US$5.2 Billion by the end of the ... Read More
-
Urology Surgical Instruments
... at a CAGR of 7.7% over the analysis period 2024-2030. Consumables & Accessories, one of the segments analyzed in the report, is expected to record a 8.2% CAGR and reach US$13.5 Billion by the end ... Read More
-
Vaginitis Therapeutics
... CAGR of 7.6% over the analysis period 2024-2030. Anti-Bacterial Product, one of the segments analyzed in the report, is expected to record a 7.4% CAGR and reach US$2.7 Billion by the end of the analysis ... Read More
-
Genomics in Cancer Care
... 2030, growing at a CAGR of 16.7% over the analysis period 2024-2030. Genomics Instruments, one of the segments analyzed in the report, is expected to record a 15.4% CAGR and reach US$25.0 Billion by the ... Read More
-
Respiratory Protection Equipment
... at a CAGR of 6.4% over the analysis period 2024-2030. Air Purifying Respirators, one of the segments analyzed in the report, is expected to record a 5.9% CAGR and reach US$15.3 Billion by the end ... Read More
-
Breastfeeding Accessories
... CAGR of 6.6% over the analysis period 2024-2030. Breastmilk Storage & Feeding, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$974.4 Million by the end of ... Read More
-
Retinal Implants
... CAGR of 7.1% over the analysis period 2024-2030. Implantable Miniature Telescope, one of the segments analyzed in the report, is expected to record a 6.7% CAGR and reach US$34.4 Million by the end of the ... Read More
-
Restorative Dentistry
... CAGR of 8.5% over the analysis period 2024-2030. Restorative Materials, one of the segments analyzed in the report, is expected to record a 9.6% CAGR and reach US$19.4 Billion by the end of the analysis ... Read More
-
Scaffold Technology
... CAGR of 7.0% over the analysis period 2024-2030. Hydrogels, one of the segments analyzed in the report, is expected to record a 7.5% CAGR and reach US$1.3 Billion by the end of the analysis period. ... Read More
-
Urothelial Cancer Drugs
... at a CAGR of 20.7% over the analysis period 2024-2030. Immunotherapy, one of the segments analyzed in the report, is expected to record a 20.3% CAGR and reach US$13.3 Billion by the end of the ... Read More
-
Intracranial Pressure (ICP) Monitoring Devices
... Billion by 2030, growing at a CAGR of 6.1% over the analysis period 2024-2030. Invasive Devices, one of the segments analyzed in the report, is expected to record a 5.9% CAGR and reach US$2.4 Billion ... Read More
-
Oncology Based In-Vivo CRO
... 2030, growing at a CAGR of 7.0% over the analysis period 2024-2030. Solid Tumors Indication, one of the segments analyzed in the report, is expected to record a 7.0% CAGR and reach US$1.2 Billion by ... Read More
-
Orthopedic Bone Cement
... at a CAGR of 4.9% over the analysis period 2024-2030. Polymethyl Methacrylate (PMMA) Cement, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$944.8 Million by the ... Read More
-
Pedicle Screw System
... at a CAGR of 4.0% over the analysis period 2024-2030. Polyaxial Pedicle Screw System, one of the segments analyzed in the report, is expected to record a 4.5% CAGR and reach US$1.6 Billion by the ... Read More
-
Cancer Immunotherapy
... CAGR of 13.7% over the analysis period 2024-2030. Monoclonal Antibodies, one of the segments analyzed in the report, is expected to record a 14.5% CAGR and reach US$266.2 Billion by the end of the analysis ... Read More
-
Cancer Stem Cells
... at a CAGR of 8.5% over the analysis period 2024-2030. Stem Cell-based Cancer Therapy, one of the segments analyzed in the report, is expected to record a 7.9% CAGR and reach US$1.3 Billion by the ... Read More
-
Cardiovascular and Soft Tissue Repair Patches
... reach US$8.3 Billion by 2030, growing at a CAGR of 7.5% over the analysis period 2024-2030. ePTFE Material, one of the segments analyzed in the report, is expected to record a 7.3% CAGR and reach ... Read More
-
Cosmetic Dentistry
... CAGR of 6.3% over the analysis period 2024-2030. Dental Systems & Equipment, one of the segments analyzed in the report, is expected to record a 7.1% CAGR and reach US$14.2 Billion by the end of ... Read More
-
Dental Fluoride Treatment
... at a CAGR of 5.2% over the analysis period 2024-2030. Toothpaste, one of the segments analyzed in the report, is expected to record a 5.1% CAGR and reach US$4.2 Billion by the end of the ... Read More
-
Disruptive Behavior Disorder (DBD) Treatment
... Billion by 2030, growing at a CAGR of 6.1% over the analysis period 2024-2030. Oppositional Defiant Disorder, one of the segments analyzed in the report, is expected to record a 6.5% CAGR and reach US$19.2 ... Read More
-
End-Stage Renal Disease
... at a CAGR of 11.7% over the analysis period 2024-2030. Hemodialysis Treatment, one of the segments analyzed in the report, is expected to record a 12.9% CAGR and reach US$209.9 Billion by the end of ... Read More
-
Hyaluronic Acid-based Dermal Fillers
... 2030, growing at a CAGR of 7.0% over the analysis period 2024-2030. Single Phase Dermal Fillers, one of the segments analyzed in the report, is expected to record a 7.3% CAGR and reach US$4.6 Billion ... Read More
-
Interventional Oncology Devices
... at a CAGR of 6.4% over the analysis period 2024-2030. Embolization Devices, one of the segments analyzed in the report, is expected to record a 7.3% CAGR and reach US$2.4 Billion by the end of ... Read More
Research Assistance
